Pure red cell aplasia induced by erythropoiesis-stimulating agents. - Wikidata - awgldk - TriplyDB

Pure red cell aplasia induced by erythropoiesis-stimulating agents.

Pure red cell aplasia induced by erythropoiesis-stimulating agents.

http://www.wikidata.org/entity/Q37051990

about

Ribavirin monotherapy for chronic hepatitis C Therapeutic developments in Friedreich ataxia Unraveling the Effect of Immunogenicity on the PK/PD, Efficacy, and Safety of Therapeutic Proteins In vivo regulation of erythropoiesis by chemically inducible dimerization of the erythropoietin receptor intracellular domain Improvement in erythropoieis-stimulating agent-induced pure red-cell aplasia by introduction of darbepoetin-α when the anti-erythropoietin antibody titer declines spontaneously.Doping in sport: effects, harm and misconceptions.Incidence of erythropoietin antibody-mediated pure red cell aplasia: the Prospective Immunogenicity Surveillance Registry (PRIMS).Epoetin zeta in the management of anemia associated with chronic kidney disease, differential pharmacology and clinical utility.Neutrophil biology and the next generation of myeloid growth factors.Biosimilar granulocyte-colony-stimulating factor for healthy donor stem cell mobilization: need we be afraid?Pharmacokinetics and toxicology of therapeutic proteins: Advances and challenges.Long-term and stable correction of uremic anemia by intramuscular injection of plasmids containing hypoxia-regulated system of erythropoietin expression.Treatment of optic neuritis with erythropoietin (TONE): a randomised, double-blind, placebo-controlled trial-study protocol.Anemia Management in the China Dialysis Outcomes and Practice Patterns Study Factors precipitating erythropoiesis-stimulating agent responsiveness in a European haemodialysis cohort: case-crossover study.Therapeutic potential of erythropoietin and its structural or functional variants in the nervous system.Erythropoietin stimulating agents in the management of anemia of chronic kidney disease.Pure red cell aplasia due to antibody against erythropoietin in hemodialysis patients.Biosimilars: current status and future directions.Glatiramer acetate and the glatiramoid class of immunomodulator drugs in multiple sclerosis: an update.Anemia of renal disease: what it is, what to do and what's new.The use of darbepoetin to stimulate erythropoiesis in anemia of chronic kidney disease in cats: 25 cases.Biosimilar therapeutics-what do we need to consider?Renal association clinical practice guideline on Anaemia of Chronic Kidney Disease.Pure red cell aplasia induced by anti-erythropoietin antibodies, well-controlled with tacrolimus.A detailed examination of the antibody prevalence and characteristics of anti-ESA antibodies.Azathioprine-induced pure red cell aplasia in a systemic sclerosis patient with interstitial pneumonia.A randomized, double-blind, phase 2 study of erythropoietin in optic neuritis.Anemia in chronic kidney disease.

P2860

Q24240057-85B9DC4A-452F-4D0B-8605-D842B7E35743 Q26861733-387BB3C0-101A-483E-92B8-6B13E162DB6E Q28066498-F0C9F72C-A69B-4EC8-910F-DB783F5E8EDB Q28544690-3B5A7524-55D9-4D48-9250-A25C30EB9D8F Q34255699-0A21352F-3BDE-4BE2-9F7F-3DD6CF620873 Q34446275-67BB8725-D66D-4C66-A02F-AB2227258AC7 Q35119023-1530ABF9-34D0-4624-8FEE-9FE087DDCF8F Q35162053-F91F1E26-DD16-4360-84F1-F02AAB19E2AB Q35653712-31EC4C1D-4AA9-4B10-82BE-FAFBCAF89FB5 Q35835005-B524FD43-59BC-4FCC-8F07-D91951158B16 Q35929084-852D3B0B-F995-43BD-863E-F53AF7451E54 Q36431079-26ED7A7E-5B84-44C8-9BF6-6CC90B727CB4 Q36670604-B3FF2AA1-9F9F-4CD9-BAA5-4076B5E331D9 Q37033628-0E4412ED-E519-4FEC-8D20-513AE0E7742F Q37257340-82E3FD7C-03C1-4156-A941-69D9CB86F87E Q37358669-BA9441F0-E7FE-420C-8B13-F3755A490031 Q37403306-120249BC-34C9-4FC0-919C-0D926C1536F0 Q37410554-796D07B6-CFF2-4F6B-88A2-D24F9E4C36DA Q37729154-FCD1BB0E-4D5F-43E8-A869-13DCA6D85E35 Q37732340-8096A6C3-4983-435D-93E7-5976B03AAA83 Q37923100-8E4B1E6C-8D41-43A5-886F-E196DB2F51F4 Q40297731-42937666-C13D-4635-8A6D-9EE5F7BB434A Q41841849-FAC43D82-F6AD-4516-82BE-792C5640F358 Q47111895-B101C691-9B7C-417C-BAAD-24EB61A5642E Q48188060-5B4D054A-72DA-41E1-ABA1-1C561819474B Q50501091-B184ED03-957E-4B39-97B8-76FD3E6CA150 Q50544820-F9F66875-2034-4AC6-9F42-9AAB7B1FD0A1 Q50916632-A1673B7A-FA1E-4E97-BB39-848403CB1893 Q53354670-29191E5D-BB78-41BE-BEA4-3C5913B00998

P2860

Pure red cell aplasia induced by erythropoiesis-stimulating agents.

http://www.wikidata.org/entity/Q37051990

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on January 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Pure red cell aplasia induced by erythropoiesis-stimulating agents.

@en

Pure red cell aplasia induced by erythropoiesis-stimulating agents.

@nl

type

label

Pure red cell aplasia induced by erythropoiesis-stimulating agents.

@en

Pure red cell aplasia induced by erythropoiesis-stimulating agents.

@nl

prefLabel

Pure red cell aplasia induced by erythropoiesis-stimulating agents.

@en

Pure red cell aplasia induced by erythropoiesis-stimulating agents.

@nl

P1433

Q37051990-888B07E8-E033-4E6C-9B05-B69CB14A44C3

P1476

Q37051990-20E59C12-C2CC-4121-8E2F-2F780307BE1F

P2093

Q37051990-0263F35D-5DFB-4A8C-8AB9-CB73FF03CA96

Q37051990-140AD52C-3292-4F22-B979-4A75EEA92204

Q37051990-298D469C-3EFD-4CA7-B283-BFCA35BA7720

Q37051990-37486230-969E-40B8-8179-997B167D7BAE

Q37051990-3EC77E07-A3EF-4ABC-A5B5-353F465E0F61

Q37051990-8C9245CB-BEAA-46E8-8496-8440761DA999

Q37051990-BA85A9D3-121F-49E8-B802-62828A950833

Q37051990-C9A4EE26-5136-456A-9D46-F2A445A42AC5

Q37051990-CA2A413D-7ED1-448A-B496-E9F252D04CC3

Q37051990-E0C66BF2-6577-4ABF-BD9F-FA22821C2F3D

P304

Q37051990-ABEC5ADB-258F-4164-B10A-E80DEB80D227

P31

Q37051990-00620E19-EAD6-49E4-A5B1-6E75901A95F0

P356

Q37051990-77D9D8E7-7DBF-43E0-9F09-C251F891A7DA

P433

Q37051990-BB5D747E-7500-466E-834A-90ABCD89696D

P478

Q37051990-0A446E6D-CD6F-4486-8676-5BE33CD5B814

P50

Q37051990-F741FD7C-E6E7-44CF-B083-5797FFDE0DB1

P577

Q37051990-D3DACB85-FC07-433F-B4A6-37ACBD1C95D6

P5875

Q37051990-7AA403FE-2DC3-424D-A8C1-EF7475EA916A

P698

Q37051990-553738D9-4761-4C94-83FA-71C723B1A75E

P356

P1433

Clinical Journal of the American Society of Nephrology

P1476

Pure red cell aplasia induced by erythropoiesis-stimulating agents

@en

P2093

Angel De Francisco

http://www.w3.org/2001/XMLSchema#string

Carol Pollock

http://www.w3.org/2001/XMLSchema#string

Edwin Toffelmire

http://www.w3.org/2001/XMLSchema#string

Huub Schellekens

http://www.w3.org/2001/XMLSchema#string

Iain Macdougall

http://www.w3.org/2001/XMLSchema#string

Jerome Rossert

http://www.w3.org/2001/XMLSchema#string

Nicole Casadevall

http://www.w3.org/2001/XMLSchema#string

Robert Delage

http://www.w3.org/2001/XMLSchema#string

Robin Thorpe

http://www.w3.org/2001/XMLSchema#string

Walter H Hörl

http://www.w3.org/2001/XMLSchema#string

P304

193-199

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2215/CJN.02440607

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P50

David W. Johnson

P577

2008-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5671117

http://www.w3.org/2001/XMLSchema#string

P698

18178785

http://www.w3.org/2001/XMLSchema#string